The OCAILab team attended the international inflammasome EMBO workshop held last week in Munich. Our team presented different posters on topics related to the NLRP1 inflammasome.
- NLRP1 a new player in SLC25A38 congenital sideroblastic anemia
- NLRP1 inhibitors as a potential treatment for ß-thalassemia major
- NLRP1 in liver of Metabolic dysfuntion-Associated SteatoHepatitis (MASH) patients
https://meetings.embo.org/event/24-inflammasomes